The last two to three years have been particularly difficult for consumers of forensic products and services due to supply chain instability and failure, as well as the alleged manipulation of test results.
This has led to the need for management of successive supply crises rather than proactive oversight and management of supplier resilience.
Commercial will therefore:
- work with the FCN community to develop and implement a consistent and proactive approach to the review of suppliers including financial due diligence;
- provide supplier and contract monitoring at a strategic level by implementing national Supplier Relationship Management (SRM) processes; gathering and collating national market management information; and undertaking regular due diligence financial, performance and accreditation checks etc.
- monitor overall contract compliance against individual contracts, using performance data provided by both FCN members and forensic providers;
- develop and maintain contingency plans for managing demand and minimising service disruption and cost impacts in the event of a major incident or market failure e.g. major quality issues or the loss of market capacity;
- work with both strategic forensic providers and FCN members to ensure that they, and the FCN as a whole, have appropriate Business Continuity and Disaster Recovery (BCDR) plans in place.
In addition to developing BCDR plans for the longer term and addressing market stability issues, Commercial will continue, where necessary, to lead on the co-ordination and oversight of short-term national issues, e.g. toxicology casework capability, where it will provide advice to FCN members and the FCN community on managing market and user demands.